Venture Capital

Updated:

Verge HealthTech

Verge HealthTech is a Singapore-based VC firm backing early-stage digital health and AI startups across emerging Asia.

Verge HealthTech logo

Verge HealthTech

Verge HealthTech is a private equity firm based in Singapore. It focuses on a Venture Capital strategy. The firm has a team of 8 staff, including 8 investment professionals.

General information

Firm type

Venture Capital

Year founded

AUM

Undisclosed

Location

Region

Asia

Country

Singapore

City

Singapore

Corporate office

Singapore

Principals

Joseph Mocanu

Managing Partner

Sector focus

Digital HealthAI/MLHealthcare Services

Frequently asked questions

Who runs investment decisions at Verge HealthTech?

Joseph Mocanu serves as Managing Partner and leads investment decisions. He founded the firm to address the lack of early-stage, health-focused technology capital in emerging Asian markets outside of China and India.

What is Verge HealthTech's geographic focus?

The firm targets Southeast Asia and South Asia, with active investments in countries including Indonesia, Vietnam, Bangladesh, and Sri Lanka. It explicitly avoids China and India as primary markets, distinguishing it from most Asia-focused health-tech funds.

Does Verge HealthTech invest in digital health exclusively?

Verge concentrates on digital health and AI-enabled healthcare services, including diagnostics, telehealth infrastructure, health data interoperability, and clinical decision support tools. It does not invest in biotech, medical devices, or traditional healthcare delivery assets.

At what stage does Verge HealthTech typically invest?

The firm focuses on seed and pre-Series A rounds, often acting as the first institutional investor. It leads or co-leads rounds and reserves capital for follow-on investments through Series A.

How is Verge HealthTech's portfolio construction distinct?

Verge runs a concentrated portfolio of 15 to 20 active positions, reflecting its narrow mandate in health-tech across specific emerging Asian geographies. This contrasts with generalist Asia seed funds that spread across sectors and larger markets.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Singapore Venture Capital profiles